Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma

Cancer. 1984 Jun 1;53(11):2472-7. doi: 10.1002/1097-0142(19840601)53:11<2472::aid-cncr2820531118>3.0.co;2-a.

Abstract

Two cases of gastrin releasing peptide (GRP)-producing medullary thyroid carcinoma are presented. Immunohistochemical examination revealed the presence of GRP-like immunoreactivity (IR-GRP) in the primary tumor tissues. High concentration of IR-GRP was also demonstrated in extracts of the primary tumors by radioimmunologic means with use of a GRP-specific antiserum. Chromatographic analysis showed that the immunoreactivity was composed of at least two molecular forms: one behaved as synthetic porcine GRP on Sephadex G-50 gel filtration and the other as porcine GRP (14-27), a C-terminal active fragment of GRP. The IR-GRP was shown not to be attributed to bombesin-like immunoreactivity. Substance P-like immunoreactivity was not detected in the tumor tissues by either immunohistochemical or radioimmunologic means. This is, as far as the authors are aware, the first finding of IR-GRP as an ectopic product in medullary carcinoma.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Calcitonin / metabolism
  • Carcinoma / metabolism*
  • Chromatography, Gel
  • Female
  • Gastrin-Releasing Peptide
  • Histocytochemistry
  • Humans
  • Immunologic Techniques
  • Middle Aged
  • Peptides / isolation & purification
  • Peptides / metabolism*
  • Radioimmunoassay
  • Thyroid Neoplasms / metabolism*
  • Tissue Extracts / analysis

Substances

  • Peptides
  • Tissue Extracts
  • Gastrin-Releasing Peptide
  • Calcitonin